By transfection with TxAS-siRNA, cell proliferative ability of both A549 and NCI-H460 was effectively inhibited, further supporting the positive role of TxAS in lung cancer [10], [11], [16]. This evidence concerns the gene TBXAS1 and lung carcinoma.